Published in Ann Surg on July 01, 1976
Acid and endocrine responses to meals varying in pH in normal and duodenal ulcer subjects. Ann Surg (1977) 0.86
Radioimmunoassay study of hepatic clearance and disappearance half-time of somatostatin and vasoactive intestinal peptide in dogs. Gut (1981) 0.84
ECL-cell histamine mobilization in conscious rats: effects of locally applied regulatory peptides, candidate neurotransmitters and inflammatory mediators. Br J Pharmacol (2001) 0.83
Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat. Proc Natl Acad Sci U S A (1993) 0.80
Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med (Maywood) (2017) 0.76
Polypeptide with broad biological activity: isolation from small intestine. Science (1970) 4.14
Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet (1973) 3.22
Inhibitory effect of pancreatic secretin on gastric secretion. Am J Physiol (1957) 2.66
Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide". Gastroenterology (1972) 2.05
Effect of secretin on circulating gastrin. Ann Surg (1972) 2.03
A gastric inhibitory polypeptide. II. The complete amino acid sequence. Can J Biochem (1971) 1.61
The effect of glucagon on gastric secretion in man. Gastroenterology (1959) 1.55
Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome. Surg Gynecol Obstet (1975) 1.53
Dynamic characteristics of gastrin release. Am J Surg (1972) 1.53
Radioimmunoassay for gastric inhibitory polypeptide. Gastroenterology (1974) 1.36
Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature (1970) 1.30
Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide. Proc Soc Exp Biol Med (1973) 1.22
Structural evidence for glucagon producing cells in the intestinal mucosa of the rat. Diabetologia (1968) 1.18
Effect of glucagon on gastric secretion. Proc Soc Exp Biol Med (1957) 1.18
Effect of Glucagon on Gastric Secretion in Man. Gut (1960) 1.03
Effect of glucagon on circulating gastrin. Gastroenterology (1973) 0.99
Effect of secretin on the serum gastrin response to a meal in man and in dog. Surg Forum (1971) 0.88
A multiparameter study on the action of preparations containing cholecystokinin-pancreozymin. Scand J Gastroenterol (1970) 0.86
Interlaboratory reproducibility of gastrin measurements by radioimmunoassay. J Lab Clin Med (1975) 0.84
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet (1987) 4.97
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (1997) 4.82
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80
Ghrelin causes hyperphagia and obesity in rats. Diabetes (2001) 3.62
A glucagonoma syndrome. Lancet (1974) 3.56
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet (1973) 3.22
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet (1976) 3.08
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Rapid calculation of radioimmunoassay results. J Lab Clin Med (1969) 2.93
Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology (2005) 2.80
Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut (1971) 2.75
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Neuron-specific enolase is produced by neuroendocrine tumours. Lancet (1981) 2.63
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Behavioral changes in Huntington Disease. Neuropsychiatry Neuropsychol Behav Neurol (2001) 2.52
Measurement of fasting and postprandial plasma VIP in man. Gut (1978) 2.48
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48
Statistical quality control of radioimmunoassays. J Clin Endocrinol Metab (1968) 2.41
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol (2004) 2.27
Gut-hormone profile in coeliac disease. Lancet (1978) 2.25
Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. Lancet (1989) 2.25
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab (2001) 2.24
Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 2.20
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Gut hormones and appetite control. Gastroenterology (2007) 2.16
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet (1975) 2.04
Effect of secretin on circulating gastrin. Ann Surg (1972) 2.03
The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf. J Physiol (1973) 2.01
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg (2006) 1.91
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes (1999) 1.90
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci (1984) 1.88
Effects of stimulation of the chorda tympani in bursts on submaxillary responses in the cat. J Physiol (1982) 1.84
Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies. J Clin Invest (1967) 1.82
Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles. Recent Prog Horm Res (1970) 1.82
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol (1990) 1.80
Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet (1977) 1.75
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 1.75
Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 1.74
The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon. Br J Surg (1974) 1.73
Bombesin-like immunoreactivity in the lung. Nature (1978) 1.73
Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab (1996) 1.72
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71
Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology (1980) 1.70
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
An enteroglucagon tumour. Gut (1972) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Knowledge of famous faces and names in semantic dementia. Brain (2004) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci (1979) 1.67
Gonadotropins and their subunits: basic and clinical studies. Recent Prog Horm Res (1976) 1.66
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
A radioimmunoassay for neurotensin in human plasma. J Endocrinol (1979) 1.66
Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest (1995) 1.66
Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology (1999) 1.65
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab (2002) 1.65
Changing trends in the management of phaeochromocytoma. Br J Surg (1998) 1.62
Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat. J Physiol (1980) 1.62
Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) (2005) 1.62
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut (1996) 1.60
Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia (1990) 1.58
The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf. J Physiol (1974) 1.58
Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation. Surgery (1993) 1.57
Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology (1991) 1.57
Effect of neurotensin on gastric function in man. Lancet (1980) 1.55
Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience (1985) 1.55
Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome. Surg Gynecol Obstet (1975) 1.53
Dynamic characteristics of gastrin release. Am J Surg (1972) 1.53
Endocrine responses to insulin hypoglycaemia in the young calf. J Physiol (1975) 1.52
Release of glucagon, induced by stress. Q J Exp Physiol Cogn Med Sci (1973) 1.51
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut (2005) 1.49
Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci U S A (1984) 1.49
Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature (1977) 1.47
Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child (1992) 1.46
Lithium intoxication. BMJ (1991) 1.45
Influence of hypercalcemia on gastric secretion and serum gastrin concentrations in man. Ann Surg (1970) 1.45
Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A (1989) 1.44
Pancreatic cholera due to production of gastric inhibitory polypeptide. Lancet (1972) 1.44
Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology (1985) 1.44
Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab (2004) 1.43
New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet (1991) 1.43
Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release. Postgrad Med J (1976) 1.42
Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin Endocrinol (Oxf) (1985) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Influence of endogenous prostaglandins on secretin-mediated inhibition of gastric acid secretion in dogs. Gastroenterology (1988) 1.42